Page 109 - ITPS-7-3

INNOSC Theranostics and
Pharmacological Sciences Alpha-2A receptor agonist and addiction

hyperactivity in opioid withdrawal supported by doi: 10.1007/BF02431544
clonidine reversal of opioid withdrawal. Am J Psychiatry. 54. Kimes AS, Bell JA, London ED. Clonidine attenuates
1979;136(1):100-102. increased brain glucose metabolism during naloxone-
doi: 10.1176/ajp.136.1.100 precipitated morphine withdrawal. Neuroscience.
1990;34(3):633-644.
43. Redmond DE Jr. Boehringer Ingelheim International
GmbH, Assignee. Method of Eliminating Opioid Withdrawal doi: 10.1016/0306-4522(90)90170-9
Symptoms with Clonidine in Humans. United States Patent 55. Gold MS, Kleber HD. Clinical utility of clonidine in opioid
US 4,312,878; 1982.
withdrawal: A study of 100 patients. Prog Clin Biol Res.
44. Blum K, Wallace JE. Effects of catecholamine synthesis 1981;71:299-306.
inhibition on ethanol-induced withdrawal symptoms in 56. Washton AM, Resnick RB. Outpatient opioid detoxification
mice. Br J Pharmacol. 1974;51(1):109-111. with clonidine. J Clin Psychiatry. 1982;43(6 Pt 2):39-41.
doi: 10.1111/j.1476-5381.1974.tb09640.x 57. Sullivan M, Bisaga A, Pavlicova M, et al. Long-acting
45. Blum K, Eubanks JD, Wallace JE, Schwertner H, injectable naltrexone induction: A randomized trial of
Morgan WW. Possible role of tetrahydroisoquinoline outpatient opioid detoxification with naltrexone versus
alkaloids in postalcohol intoxication states. Ann N Y Acad buprenorphine. Am J Psychiatry. 2017;174(5):459-467.
Sci. 1976;273:234-246. doi: 10.1176/appi.ajp.2016.16050548
doi: 10.1111/j.1749-6632.1976.tb52887.x 58. Gold MS, Dackis CA, Washton AM. The sequential use of
46. Blum K, Eubanks JD, Wallace JE, Schwertner HA. clonidine and naltrexone in the treatment of opioid addicts.
Suppression of ethanol withdrawal by dopamine. Adv Alcohol Subst Abuse. 1984;3(3):19-39.
Experientia. 1976;32(4):493-495. doi: 10.1300/J251v03n03_03
doi: 10.1007/BF01920816 59. Charney DS, Heninger GR, Kleber HD. The combined use
47. Blum K, Eubanks JD, Wiggins B, Wallace JE. Morphine of clonidine and naltrexone as a rapid, safe, and effective
withdrawal reactions in male and female mice. Am J Drug treatment of abrupt withdrawal from methadone. Am J
Alcohol Abuse. 1976;3(2):363-368. Psychiatry. 1986;143(7):831-837.
doi: 10.3109/00952997609077204 doi: 10.1176/ajp.143.7.831
48. Blum K, Wallace JE, Schwerter HA, Eubanks JD. Morphine 60. Gowing L, Farrell MF, Ali R, White JM. Alpha2-adrenergic
suppression of ethanol withdrawal in mice. Experientia. agonists for the management of opioid withdrawal. Cochrane
1976;32(1):79-82. Database Syst Rev. 2014;(3):CD002024.

doi: 10.1007/BF01932634 doi: 10.1002/14651858.CD002024.pub4. Update in:
Cochrane Database Syst Rev. 2016;(5):CD002024
49. Blum K, Wallace JE, Schwertner HA, Eubanks JD.
Enhancement of ethanol-induced withdrawal convulsions 61. Kowalczyk WJ, Moran LM, Bertz JW, et al. Using
by blockade of 5-hydroxytryptamine receptors. J Pharm ecological momentary assessment to examine the
Pharmacol. 1976;28(11):832-835. relationship between craving and affect with opioid use
in a clinical trial of clonidine as an adjunct medication
doi: 10.1111/j.2042-7158.1976.tb04066.x to buprenorphine treatment. Am J Drug Alcohol Abuse.
50. Blum K, Briggs AH, DeLallo L. Clonidine enhancement of 2018;44(5):502-511.
ethanol withdrawal in mice. Subst Alcohol Actions Misuse. doi: 10.1080/00952990.2018.1454933
1983;4(1):59-63.
62. Kowalczyk WJ, Phillips KA, Jobes ML, et al. clonidine
51. Gold MS, Pottash AC, Sweeney DR, Extein I, Annitto WJ. maintenance prolongs opioid abstinence and decouples
Lofexidine blocks acute opioid withdrawal. NIDA Res stress from craving in daily life: A randomized controlled
Monogr. 1982;41:264-268. trial with ecological momentary assessment. Am J Psychiatry.
52. Washton AM, Pottash AC, Gold MS. Naltrexone in addicted 2015;172(8):760-767.
business executives and physicians. J Clin Psychiatry. doi: 10.1176/appi.ajp.2014.14081014
1984;45(9 Pt 2):39-41.
63. Kosten TR, Baxter LE. Review article: Effective management
53. Taylor JR, Elsworth JD, Garcia EJ, Grant SJ, Roth RH, of opioid withdrawal symptoms: A gateway to opioid
Redmond DE Jr. Clonidine infusions into the locus dependence treatment. Am J Addict. 2019;28(2):55-62.
coeruleus attenuate behavioral and neurochemical
changes associated with naloxone-precipitated withdrawal. doi: 10.1111/ajad.12862
Psychopharmacology (Berl). 1988;96(1):121-134. 64. Rehman SU, Maqsood MH, Bajwa H, Tameez Ud Din A,

Volume 7 Issue 3 (2024) 15 doi: 10.36922/itps.1918